159 related articles for article (PubMed ID: 36535915)
1. Association of Cardiovascular Disease Risk Factors with Exclusive Smokeless Tobacco Use among US Males: Cross-Sectional Analysis of NHANES Data 2003-2018.
Mushtaq N; Sarwar Z; Kouplen K; Ahmed R; Beebe LA
Am J Health Promot; 2023 Jun; 37(5):614-624. PubMed ID: 36535915
[TBL] [Abstract][Full Text] [Related]
2. A National Comparison of Dual Users of Smokeless Tobacco and Cigarettes and Exclusive Cigarette Smokers, 2015-2016.
Jones DM; Popova L; Weaver SR; Pechacek TF; Eriksen MP
Nicotine Tob Res; 2018 Aug; 20(suppl_1):S62-S70. PubMed ID: 30125015
[TBL] [Abstract][Full Text] [Related]
3. Associations of Smokeless Tobacco Use With Cardiovascular Disease Risk: Insights From the Population Assessment of Tobacco and Health Study.
Rezk-Hanna M; Warda US; Stokes AC; Fetterman J; Li J; Macey PM; Darawad M; Song Y; Ben Taleb Z; Brecht ML; Benowitz NL
Nicotine Tob Res; 2022 Jun; 24(7):1063-1070. PubMed ID: 34999825
[TBL] [Abstract][Full Text] [Related]
4. Nicotine and Toxicant Exposure among U.S. Smokeless Tobacco Users: Results from 1999 to 2012 National Health and Nutrition Examination Survey Data.
Rostron BL; Chang CM; van Bemmel DM; Xia Y; Blount BC
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1829-37. PubMed ID: 26582044
[TBL] [Abstract][Full Text] [Related]
5. Time to First Use Among Daily Smokers and Smokeless Tobacco Users.
Rodu B; Plurphanswat N; Fagerström K
Nicotine Tob Res; 2015 Jul; 17(7):882-5. PubMed ID: 25358658
[TBL] [Abstract][Full Text] [Related]
6. Smokeless Tobacco Use and Prevalence of Cardiovascular Disease Among Males in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1-4.
Nahhas GJ; Cummings KM; Halenar MJ; Sharma E; Alberg AJ; Hatuskami D; Bansal-Travers M; Hyland A; Gaalema DE; Morris PB; Duffy K; Chang JT; Lagaud G; Vivar JC; Marshall D; Blanco C; Taylor KA
Prev Med Rep; 2022 Feb; 25():101650. PubMed ID: 35127346
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of Potential Harm among Adult Cigarette and Smokeless Tobacco Users in the PATH Study Wave 1 (2013-2014): A Cross-sectional Analysis.
Chang JT; Vivar JC; Tam J; Hammad HT; Christensen CH; van Bemmel DM; Das B; Danilenko U; Chang CM
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1320-1327. PubMed ID: 33947655
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Urinary Biomarkers of Exposure in Humans Using Electronic Cigarettes, Combustible Cigarettes, and Smokeless Tobacco.
Lorkiewicz P; Riggs DW; Keith RJ; Conklin DJ; Xie Z; Sutaria S; Lynch B; Srivastava S; Bhatnagar A
Nicotine Tob Res; 2019 Aug; 21(9):1228-1238. PubMed ID: 29868926
[TBL] [Abstract][Full Text] [Related]
9. Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players.
Siegel D; Benowitz N; Ernster VL; Grady DG; Hauck WW
Am J Public Health; 1992 Mar; 82(3):417-21. PubMed ID: 1536359
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the Tobacco Dependence Screener Among Smokeless Tobacco Users.
Mushtaq N; Beebe LA
Nicotine Tob Res; 2016 May; 18(5):885-91. PubMed ID: 26718743
[TBL] [Abstract][Full Text] [Related]
11. Determinants of salivary cotinine concentrations among smokeless tobacco users.
Mushtaq N; Beebe LA; Vesely SK
Nicotine Tob Res; 2012 Oct; 14(10):1229-34. PubMed ID: 22180597
[TBL] [Abstract][Full Text] [Related]
12. Use of smokeless tobacco and risk of cardiovascular disease: A systematic review and meta-analysis.
Vidyasagaran AL; Siddiqi K; Kanaan M
Eur J Prev Cardiol; 2016 Dec; 23(18):1970-1981. PubMed ID: 27256827
[TBL] [Abstract][Full Text] [Related]
13. Determinants of Salivary Cotinine among Smokeless Tobacco Users: A Cross-Sectional Survey in Bangladesh.
Huque R; Shah S; Mushtaq N; Siddiqi K
PLoS One; 2016; 11(8):e0160211. PubMed ID: 27504912
[TBL] [Abstract][Full Text] [Related]
14. Mortality among male smokers and smokeless tobacco users in the USA.
Rodu B; Plurphanswat N
Harm Reduct J; 2019 Aug; 16(1):50. PubMed ID: 31429765
[TBL] [Abstract][Full Text] [Related]
15. Validity of self reports in a cohort of Swedish adolescent smokers and smokeless tobacco (snus) users.
Post A; Gilljam H; Rosendahl I; Meurling L; Bremberg S; Galanti MR
Tob Control; 2005 Apr; 14(2):114-7. PubMed ID: 15791021
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of tobacco dependence measures in South Asian smokeless tobacco users.
Mushtaq N; Huque R; Beebe LA; Shah S; Siddiqi K
Drug Alcohol Depend; 2019 Oct; 203():66-71. PubMed ID: 31404851
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Salivary Cotinine Concentrations in Male Smokers and Smokeless Tobacco Users.
Honarmand M; Nakhaee A; Moradi M
Asian Pac J Cancer Prev; 2018 May; 19(5):1363-1366. PubMed ID: 29802701
[TBL] [Abstract][Full Text] [Related]
18. Patterns of dual use of cigarettes and smokeless tobacco among US males: findings from national surveys.
Tomar SL; Alpert HR; Connolly GN
Tob Control; 2010 Apr; 19(2):104-9. PubMed ID: 20008157
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the role of smokeless tobacco use indices as brief measures of dependence.
Mushtaq N; Beebe LA
Addict Behav; 2017 Jun; 69():87-92. PubMed ID: 28214708
[TBL] [Abstract][Full Text] [Related]
20. Re-visiting serum cotinine concentrations among various types of smokers including cigarette only smokers: some new, previously unreported results.
Jain RB
Environ Sci Pollut Res Int; 2021 Jan; 28(3):3149-3161. PubMed ID: 32902748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
